Gene Review:
Cd320 - CD320 antigen
Mus musculus
Synonyms:
425O18-1, 8D6, CD320-002, D17Ertd716e, NG29, ...
- A mouse model with features of familial combined hyperlipidemia. Masucci-Magoulas, L., Goldberg, I.J., Bisgaier, C.L., Serajuddin, H., Francone, O.L., Breslow, J.L., Tall, A.R. Science (1997)
- Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. Watanabe, M., Houten, S.M., Wang, L., Moschetta, A., Mangelsdorf, D.J., Heyman, R.A., Moore, D.D., Auwerx, J. J. Clin. Invest. (2004)
- Fat feeding in humans induces lipoproteins of density less than 1.006 that are enriched in apolipoprotein [a] and that cause lipid accumulation in macrophages. Bersot, T.P., Innerarity, T.L., Pitas, R.E., Rall, S.C., Weisgraber, K.H., Mahley, R.W. J. Clin. Invest. (1986)
- Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice. van Vlijmen, B.J., van den Maagdenberg, A.M., Gijbels, M.J., van der Boom, H., HogenEsch, H., Frants, R.R., Hofker, M.H., Havekes, L.M. J. Clin. Invest. (1994)
- Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors. Kashyap, V.S., Santamarina-Fojo, S., Brown, D.R., Parrott, C.L., Applebaum-Bowden, D., Meyn, S., Talley, G., Paigen, B., Maeda, N., Brewer, H.B. J. Clin. Invest. (1995)
- Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. Lin, J., Yang, R., Tarr, P.T., Wu, P.H., Handschin, C., Li, S., Yang, W., Pei, L., Uldry, M., Tontonoz, P., Newgard, C.B., Spiegelman, B.M. Cell (2005)
- Remnant lipoproteins inhibit malaria sporozoite invasion of hepatocytes. Sinnis, P., Willnow, T.E., Briones, M.R., Herz, J., Nussenzweig, V. J. Exp. Med. (1996)
- Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice. Ebara, T., Conde, K., Kako, Y., Liu, Y., Xu, Y., Ramakrishnan, R., Goldberg, I.J., Shachter, N.S. J. Clin. Invest. (2000)
- Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. Raabe, M., Véniant, M.M., Sullivan, M.A., Zlot, C.H., Björkegren, J., Nielsen, L.B., Wong, J.S., Hamilton, R.L., Young, S.G. J. Clin. Invest. (1999)
- Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase. Jeong, T.s., Schissel, S.L., Tabas, I., Pownall, H.J., Tall, A.R., Jiang, X. J. Clin. Invest. (1998)
- PPARdelta is a very low-density lipoprotein sensor in macrophages. Chawla, A., Lee, C.H., Barak, Y., He, W., Rosenfeld, J., Liao, D., Han, J., Kang, H., Evans, R.M. Proc. Natl. Acad. Sci. U.S.A. (2003)
- Transgenic mice expressing human lipoprotein lipase driven by the mouse metallothionein promoter. A phenotype associated with increased perinatal mortality and reduced plasma very low density lipoprotein of normal size. Zsigmond, E., Scheffler, E., Forte, T.M., Potenz, R., Wu, W., Chan, L. J. Biol. Chem. (1994)
- An immunosuppressive lipoprotein fraction from TEPC-183 bearing mice. Wolfe, L., Havas, H.F., Fenton, M.R. Clin. Exp. Immunol. (1983)
- Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT. Kypreos, K.E., Zannis, V.I. Biochem. J. (2007)
- Lipolytic surface remnants of triglyceride-rich lipoproteins are cytotoxic to macrophages but not in the presence of high density lipoprotein. A possible mechanism of atherogenesis? Chung, B.H., Segrest, J.P., Smith, K., Griffin, F.M., Brouillette, C.G. J. Clin. Invest. (1989)
- Lipoprotein lipase expression exclusively in liver. A mouse model for metabolism in the neonatal period and during cachexia. Merkel, M., Weinstock, P.H., Chajek-Shaul, T., Radner, H., Yin, B., Breslow, J.L., Goldberg, I.J. J. Clin. Invest. (1998)
- Peroxisome proliferator-activated receptor delta promotes very low-density lipoprotein-derived fatty acid catabolism in the macrophage. Lee, C.H., Kang, K., Mehl, I.R., Nofsinger, R., Alaynick, W.A., Chong, L.W., Rosenfeld, J.M., Evans, R.M. Proc. Natl. Acad. Sci. U.S.A. (2006)
- Overexpression of apolipoprotein E in transgenic mice: marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemia. Shimano, H., Yamada, N., Katsuki, M., Shimada, M., Gotoda, T., Harada, K., Murase, T., Fukazawa, C., Takaku, F., Yazaki, Y. Proc. Natl. Acad. Sci. U.S.A. (1992)
- Stimulation of cholesteryl ester synthesis in mouse peritoneal macrophages by cholesterol-rich very low density lipoproteins from the Watanabe heritable hyperlipidemic rabbit, an animal model of familial hypercholesterolemia. Kita, T., Yokode, M., Watanabe, Y., Narumiya, S., Kawai, C. J. Clin. Invest. (1986)
- Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E- deficient mouse hepatocytes. Kuipers, F., Jong, M.C., Lin, Y., Eck, M., Havinga, R., Bloks, V., Verkade, H.J., Hofker, M.H., Moshage, H., Berkel, T.J., Vonk, R.J., Havekes, L.M. J. Clin. Invest. (1997)
- Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor. Frykman, P.K., Brown, M.S., Yamamoto, T., Goldstein, J.L., Herz, J. Proc. Natl. Acad. Sci. U.S.A. (1995)
- Troglitazone action is independent of adipose tissue. Burant, C.F., Sreenan, S., Hirano, K., Tai, T.A., Lohmiller, J., Lukens, J., Davidson, N.O., Ross, S., Graves, R.A. J. Clin. Invest. (1997)
- Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles. Aalto-Setälä, K., Fisher, E.A., Chen, X., Chajek-Shaul, T., Hayek, T., Zechner, R., Walsh, A., Ramakrishnan, R., Ginsberg, H.N., Breslow, J.L. J. Clin. Invest. (1992)
- Intestinal expression of human apolipoprotein A-IV in transgenic mice fails to influence dietary lipid absorption or feeding behavior. Aalto-Setälä, K., Bisgaier, C.L., Ho, A., Kieft, K.A., Traber, M.G., Kayden, H.J., Ramakrishnan, R., Walsh, A., Essenburg, A.D., Breslow, J.L. J. Clin. Invest. (1994)
- Very-low-density lipoprotein binding to the apolipoprotein E receptor 2 is enhanced by lipoprotein lipase, and does not require apolipoprotein E. Tacken, P.J., Beer, F.D., Vark, L.C., Havekes, L.M., Hofker, M.H., Willems Van Dijk K, n.u.l.l. Biochem. J. (2000)
- Inhibition of macrophage-mediated tumor cell destruction by oxidized lipoproteins. Justement, L.B., Patel, S.T., Newman, H.A., Zwilling, B.S. J. Natl. Cancer Inst. (1984)
- Relationship of an abnormal plasma lipoprotein to protection from atherosclerosis in the cholesterol-fed diabetic rabbit. Brecher, P., Chobanian, A.V., Small, D.M., Van Sickle, W., Tercyak, A., Lazzari, A., Baler, J. J. Clin. Invest. (1983)